Click here to read the previous top cannabis stocks year-to-date list.
As the door closes on 2020, the Investing News Network is looking back on the operating year to see which cannabis stocks performed the best.
Investors looking for an edge with cannabis this year had a turbulent ride as the effects of the COVID-19 pandemic affected virtually every market. However, the cannabis arena did have a few key wins.
As the industry moved forward, some companies in the marijuana space secured positive returns for the year as they continued to make progress at their businesses.
Data for this top cannabis stocks year-to-date article was collected on December 15, 2020, and the companies included had to meet a minimum market cap requirement of C$10 million. Cannabis companies on the NYSE, NASDAQ, TSX, TSXV and CSE were considered.
1. Vibe Growth (CSE:VIBE,OTC Pink:VBSCF)
Year-to-date gain: 544.44 percent; current market cap: C$41.58 million; current share price: C$0.55
Vibe Growth is a cannabis company based in the expansive California state market. This retailer and operator offers consumers its extensive line of products at the three stores it manages in the state.
This year, the company has focused predominantly on its operations in California by acquiring a second facility and confirming expansion plans for existing facilities. Vibe Growth did also expand beyond California in 2020 by securing a deal for a dispensary based in Portland, Oregon.
2. TerrAscend (CSE:TER,OTCQX:TRSSF)
Year-to-date gain: 321.59 percent; current market cap: C$971.02 million; current share price: C$12.95
TerrAscend is a cannabis operator predominantly focused on opportunities in the US marketplace. The company had a straightforward growth path on the open market this year, seeing its share price increase as the firm kept advancing its expansion plans.
“We’re driving strong revenue growth and continued margin expansion by focusing on operational excellence, controlled SG&A spending, and strategically allocating our capital,” Jason Ackerman, CEO and executive chairman of TerrAscend, said as part of a Q3 financial statement from the company.
3. Next Green Wave Holdings (CSE:NGW,OTCQX:NXGWF)
Year-to-date gain: 250 percent; current market cap: C$56.22 million; current share price: C$0.33
Despite seeing a dip in value earlier in the year, Next Green Wave Holdings picked up steam in the second half of 2020 and delivered a solid end-of-year performance for its investors.
The established seed-to-sale operator in the California state cannabis market recently confirmed plans for a new cultivation facility in Coalinga as it seeks to up its production numbers by about 150 percent per year.
Next Green Wave has shown steady operating performance this year; it confirmed that in July, August and September it saw positive cash flow and profitability. By November, the company had reached over US$1 million in revenues for each month of Q3.
4. Icanic Brands (CSE:ICAN,OTCQB:ICNAF)
Year-to-date gain: 204.55 percent; current market cap: C$127.90 million; current share price: C$0.65
Icanic Brands is a cannabis company with operations in California and Nevada that exclusively sells branded products. The company mainly highlights its brand Ganja Gold, and has indicated that it plans to introduce additional SKUs for this brand.
“For our Company, 2020 was always meant to be a year to solidify our company’s foundation in preparation for our future while trying to meet the increasing demand for our products,” Brandon Kou, CEO of Icanic, said as part of the company’s report for the 2020 fiscal year.
5. Jushi Holdings (CSE:JUSH,OTCQB:JUSHF)
Year-to-date gain: 190 percent; current market cap: C$669.22 million; current share price: C$6
Jushi Holdings is a multi-state operator focused on the US cannabis space. The company runs a vertically integrated business overseeing cannabis cultivation, brand curation and retail management.
As part of its Q3 financial results, Jim Cacioppo, CEO, chairman and founder of Jushi, said the company was raising the floor on its Q4 revenue guidance to an increased margin of US$28 million to US$30 million.
“We continued to see strong momentum in the business as we exited the third quarter, and as a result, we expect to see further expansion in revenue and profitability through the balance of the year,” Cacioppo said.
Despite the challenging nature of 2020 and its impact on the financial markets, some cannabis companies were able to pull through. Beyond these top five stocks, the industry saw substantial growth from companies in the US sector, a marketplace that is expected to only go up from now on.
Want more details? Check out these articles for more INNdepth coverage:
- Cannabis Investment: Canadian Cannabis Stocks
- Invest in Cannabis: TSX Cannabis Stocks
- Cannabis Companies: Stocks on the TSXV
- 10 Small-cap Cannabis Stocks
- 10 Big-cap Canadian Cannabis Stocks
- CSE Marijuana Stocks
- Cannabis Stocks on the CSE25 Index
- Are Canadian Marijuana Stocks a Good Investment?
Want an overview of investing in cannabis stocks? Check out Investing in the Cannabis Industry.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Meanwhile, two longstanding cannabis partners ended their relationship.
Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development
Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.
The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.
With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.
DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.